Trial reportNature and science of sleep2026
Acupuncture with the Sancai Acupoint Matching Method for Primary Insomnia: A Randomized Controlled Trial.
Trial report in Nature and science of sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study Objectives: Primary insomnia (PI) remains a widespread public health concern. This study aims to evaluate the efficacy and safety of the novel Sancai acupoint matching method for PI, and to explore its potential peripheral biochemical mechanisms. Methods and Design: 76 PI patients were randomly assigned to either the real-acupuncture (RA) group or the sham-acupuncture (SA) group, with 38 cases in each group. The RA group received verum acupuncture based on the stated principle over an 8-week treatment period (20 sessions), while the SA group received sham acupuncture. Assessments were conducted at baseline, immediately post-treatment, and at 1, 4- and 12-week follow-ups using the Insomnia Severity Index (ISI) as the primary outcome measure, along with the Pittsburgh Sleep Quality Index (PSQI), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS). Objective sleep parameters were monitored via polysomnography (PSG), and serum levels of 5-hydroxytryptamine (5-HT) and brain-derived neurotrophic factor (BDNF) were measured before and after treatment. Results: Improvements in ISI, PSQI, SAS and SDS scores were superior in the RA group compared to the SA group ( Conclusion: The Sancai acupoint matching method is a safe and effective treatment for primary insomnia, significantly improving patients' subjective sleep quality, emotional symptoms, and objective sleep parameters, and upregulating peripheral blood levels of 5-HT and BDNF. These findings support the clinical application of this acupuncture protocol and provide a foundation for subsequent mechanistic studies. Clinical Trial Registration: The study was registered at the Chinese Clinical Trial.Registry, registration ID: ChiCTR2300072229, China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.